- Country: South Korea
- Summary: Evaluation of Anticancer Immunotherapy Efficacy and Immune Activity of Humanized Mouse-Based Lead Substance
- KRT Ref No: 129146268
- Deadline: 10 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 90886364
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEvaluation of Anticancer Immunotherapy Efficacy and Immune Activity of Humanized Mouse-Based Lead Substance - Korea Tender
The KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, a Government sector organization in South Korea, has announced a new tender for Evaluation of Anticancer Immunotherapy Efficacy and Immune Activity of Humanized Mouse-Based Lead Substance. This tender is published on KoreaTenders under KRT Ref No: 129146268 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-10.
The estimated tender value is KRW 90886364, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
